Patrick J. Christmas Regenxbio Inc. (RGNX) insider trading activity

RGNX Quotes by TradingView

Patrick J. Christmas is Chief Legal Officer of REGENXBIO Inc.. Currently has a direct ownership of 160,810 shares of RGNX, which is worth approximately $1.21 Million. The most recent transaction as insider was on Jan 02, 2025, when has been sold 11,395 shares (Common Stock) at a price of $7.73 per share, resulting in proceeds of $88,083. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 161K
6.62% 3M change
98.18% 12M change
Total Value Held $1.21 Million

Patrick J. Christmas Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 02 2025
SELL
Payment of exercise price or tax liability
$88,083 $7.73 p/Share
11,395 Reduced 6.62%
160,810 Common Stock
Aug 01 2024
BUY
Grant, award, or other acquisition
-
56,446 Added 24.69%
172,205 Common Stock
Jan 02 2024
SELL
Payment of exercise price or tax liability
$141,679 $17.95 p/Share
7,893 Reduced 8.86%
81,144 Common Stock
Jan 02 2024
BUY
Grant, award, or other acquisition
-
34,615 Added 23.02%
115,759 Common Stock
Jan 03 2023
SELL
Payment of exercise price or tax liability
$41,799 $22.68 p/Share
1,843 Reduced 8.03%
21,097 Common Stock
Jan 03 2023
BUY
Grant, award, or other acquisition
-
67,940 Added 43.28%
89,037 Common Stock
Jan 03 2022
BUY
Grant, award, or other acquisition
-
7,900 Added 25.62%
22,940 Common Stock
Jan 01 2022
SELL
Payment of exercise price or tax liability
$43,556 $32.7 p/Share
1,332 Reduced 8.14%
15,040 Common Stock
Feb 12 2021
SELL
Open market or private sale
$230,725 $49.08 p/Share
4,701 Reduced 22.31%
16,372 Common Stock
Feb 12 2021
BUY
Exercise of conversion of derivative security
$56,882 $12.1 p/Share
4,701 Added 18.24%
21,073 Common Stock
Feb 08 2021
SELL
Open market or private sale
$63,843 $49.11 p/Share
1,300 Reduced 7.36%
16,372 Common Stock
Feb 08 2021
BUY
Exercise of conversion of derivative security
$15,730 $12.1 p/Share
1,300 Added 6.85%
17,672 Common Stock
Feb 02 2021
SELL
Open market or private sale
$449,500 $44.95 p/Share
10,000 Reduced 37.92%
16,372 Common Stock
Feb 02 2021
BUY
Exercise of conversion of derivative security
$121,000 $12.1 p/Share
10,000 Added 27.49%
26,372 Common Stock
Jan 12 2021
SELL
Open market or private sale
$67,729 $49.15 p/Share
1,378 Reduced 7.76%
16,372 Common Stock
Jan 12 2021
BUY
Exercise of conversion of derivative security
$26,871 $19.5 p/Share
1,378 Added 7.2%
17,750 Common Stock
Jan 11 2021
SELL
Open market or private sale
$496,788 $49.08 p/Share
10,122 Reduced 38.2%
16,372 Common Stock
Jan 11 2021
BUY
Exercise of conversion of derivative security
$159,928 $15.8 p/Share
10,122 Added 27.64%
26,494 Common Stock
Jan 08 2021
SELL
Open market or private sale
$473,300 $47.33 p/Share
10,000 Reduced 37.92%
16,372 Common Stock
Jan 08 2021
BUY
Exercise of conversion of derivative security
$121,000 $12.1 p/Share
10,000 Added 27.49%
26,372 Common Stock
Jan 04 2021
BUY
Grant, award, or other acquisition
-
13,800 Added 45.74%
16,372 Common Stock
PJC

Patrick J. Christmas

Chief Legal Officer
Rockville, MD

Track Institutional and Insider Activities on RGNX

Follow REGENXBIO Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RGNX shares.

Notify only if

Insider Trading

Get notified when an Regenxbio Inc. insider buys or sells RGNX shares.

Notify only if

News

Receive news related to REGENXBIO Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RGNX